Annual Operating Profit
$1.18 B
+$205.20 M+20.95%
December 31, 2023
Summary
- As of February 20, 2025, UTHR annual operating income is $1.18 billion, with the most recent change of +$205.20 million (+20.95%) on December 31, 2023.
- During the last 3 years, UTHR annual operating profit has risen by +$591.30 million (+99.61%).
- UTHR annual operating profit is now at all-time high.
Performance
UTHR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$408.20 M
+$88.30 M+27.60%
September 30, 2024
Summary
- As of February 20, 2025, UTHR quarterly operating income is $408.20 million, with the most recent change of +$88.30 million (+27.60%) on September 30, 2024.
- Over the past year, UTHR quarterly operating profit has increased by +$81.20 million (+24.83%).
- UTHR quarterly operating profit is now at all-time high.
Performance
UTHR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$1.34 B
+$81.20 M+6.43%
September 30, 2024
Summary
- As of February 20, 2025, UTHR TTM operating income is $1.34 billion, with the most recent change of +$81.20 million (+6.43%) on September 30, 2024.
- Over the past year, UTHR TTM operating profit has increased by +$244.10 million (+22.18%).
- UTHR TTM operating profit is now at all-time high.
Performance
UTHR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
UTHR Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +20.9% | +24.8% | +22.2% |
3 y3 years | +99.6% | +24.8% | +22.2% |
5 y5 years | +47.1% | +144.9% | +111.7% |
UTHR Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +113.2% | at high | +140.4% | at high | +141.9% |
5 y | 5-year | at high | +731.6% | at high | +729.9% | at high | +816.7% |
alltime | all time | at high | +731.6% | at high | +162.2% | at high | +816.7% |
United Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $408.20 M(+27.6%) | $1.34 B(+6.4%) |
Jun 2024 | - | $319.90 M(-10.2%) | $1.26 B(+0.5%) |
Mar 2024 | - | $356.30 M(+37.0%) | $1.26 B(+6.1%) |
Dec 2023 | $1.18 B(+20.9%) | $260.10 M(-20.5%) | $1.18 B(+7.7%) |
Sep 2023 | - | $327.00 M(+4.3%) | $1.10 B(+1.2%) |
Jun 2023 | - | $313.40 M(+10.2%) | $1.09 B(+11.4%) |
Mar 2023 | - | $284.40 M(+62.0%) | $976.10 M(-0.4%) |
Dec 2022 | $979.70 M(+76.2%) | $175.60 M(-44.1%) | $979.70 M(+0.6%) |
Sep 2022 | - | $314.30 M(+55.7%) | $973.90 M(+9.6%) |
Jun 2022 | - | $201.80 M(-29.9%) | $888.30 M(-2.2%) |
Mar 2022 | - | $288.00 M(+69.6%) | $908.70 M(+63.5%) |
Dec 2021 | $555.90 M(-6.4%) | $169.80 M(-25.8%) | $555.90 M(+23.2%) |
Sep 2021 | - | $228.70 M(+2.9%) | $451.40 M(+1.7%) |
Jun 2021 | - | $222.20 M(-442.9%) | $443.80 M(+22.6%) |
Mar 2021 | - | -$64.80 M(-199.2%) | $362.10 M(-39.0%) |
Dec 2020 | $593.60 M(-416.4%) | $65.30 M(-70.5%) | $593.60 M(+0.3%) |
Sep 2020 | - | $221.10 M(+57.4%) | $591.80 M(+6.8%) |
Jun 2020 | - | $140.50 M(-15.7%) | $554.10 M(-12.7%) |
Mar 2020 | - | $166.70 M(+162.5%) | $635.00 M(-438.5%) |
Dec 2019 | -$187.60 M(-123.3%) | $63.50 M(-65.4%) | -$187.60 M(+56.9%) |
Sep 2019 | - | $183.40 M(-17.2%) | -$119.60 M(-22.0%) |
Jun 2019 | - | $221.40 M(-133.8%) | -$153.40 M(-2.5%) |
Mar 2019 | - | -$655.90 M(-598.8%) | -$157.40 M(-119.5%) |
Dec 2018 | $805.40 M(-21.4%) | $131.50 M(-12.1%) | $805.40 M(-0.9%) |
Sep 2018 | - | $149.60 M(-31.2%) | $812.90 M(-17.6%) |
Jun 2018 | - | $217.40 M(-29.2%) | $987.10 M(-7.6%) |
Mar 2018 | - | $306.90 M(+120.8%) | $1.07 B(+4.2%) |
Dec 2017 | $1.02 B(-3.5%) | $139.00 M(-57.1%) | $1.02 B(-3.3%) |
Sep 2017 | - | $323.80 M(+8.5%) | $1.06 B(+8.7%) |
Jun 2017 | - | $298.50 M(+13.2%) | $974.90 M(+1.4%) |
Mar 2017 | - | $263.60 M(+51.3%) | $961.60 M(-9.4%) |
Dec 2016 | $1.06 B(+51.9%) | $174.20 M(-27.0%) | $1.06 B(+1.8%) |
Sep 2016 | - | $238.60 M(-16.3%) | $1.04 B(-12.5%) |
Jun 2016 | - | $285.20 M(-21.6%) | $1.19 B(+10.5%) |
Mar 2016 | - | $363.70 M(+134.6%) | $1.08 B(+54.1%) |
Dec 2015 | $699.00 M(+29.7%) | $155.00 M(-59.9%) | $699.00 M(-3.3%) |
Sep 2015 | - | $387.00 M(+125.3%) | $722.58 M(+138.2%) |
Jun 2015 | - | $171.80 M(-1260.8%) | $303.34 M(-1.5%) |
Mar 2015 | - | -$14.80 M(-108.3%) | $307.86 M(-42.9%) |
Dec 2014 | $538.80 M(+84.2%) | $178.58 M(-654.0%) | $538.80 M(+62.4%) |
Sep 2014 | - | -$32.24 M(-118.3%) | $331.73 M(-29.2%) |
Jun 2014 | - | $176.32 M(-18.4%) | $468.62 M(+13.0%) |
Mar 2014 | - | $216.14 M(-858.6%) | $414.60 M(+41.7%) |
Dec 2013 | $292.50 M(-30.6%) | -$28.49 M(-127.2%) | $292.50 M(-34.9%) |
Sep 2013 | - | $104.65 M(-14.4%) | $449.59 M(+5.6%) |
Jun 2013 | - | $122.30 M(+30.1%) | $425.66 M(+4.1%) |
Mar 2013 | - | $94.04 M(-26.9%) | $408.95 M(-3.0%) |
Dec 2012 | $421.65 M(+32.7%) | $128.60 M(+59.3%) | $421.65 M(+18.3%) |
Sep 2012 | - | $80.72 M(-23.6%) | $356.55 M(-5.9%) |
Jun 2012 | - | $105.59 M(-1.1%) | $378.81 M(-2.3%) |
Mar 2012 | - | $106.74 M(+68.1%) | $387.71 M(+22.0%) |
Dec 2011 | $317.78 M | $63.51 M(-38.3%) | $317.78 M(+17.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | $102.98 M(-10.1%) | $269.61 M(+17.7%) |
Jun 2011 | - | $114.49 M(+211.1%) | $229.12 M(+19.9%) |
Mar 2011 | - | $36.80 M(+140.0%) | $191.11 M(+2.4%) |
Dec 2010 | $171.31 M(+558.9%) | $15.33 M(-75.5%) | $186.55 M(+10.4%) |
Sep 2010 | - | $62.49 M(-18.3%) | $169.03 M(+42.9%) |
Jun 2010 | - | $76.48 M(+137.2%) | $118.28 M(+213.9%) |
Mar 2010 | - | $32.25 M(-1577.8%) | $37.68 M(+44.9%) |
Dec 2009 | $26.00 M(-131.7%) | -$2.18 M(-118.6%) | $26.00 M(-124.6%) |
Sep 2009 | - | $11.74 M(-384.8%) | -$105.68 M(+6.4%) |
Jun 2009 | - | -$4.12 M(-120.0%) | -$99.35 M(+30.3%) |
Mar 2009 | - | $20.57 M(-115.4%) | -$76.24 M(-7.1%) |
Dec 2008 | -$82.06 M(-1401.9%) | -$133.86 M(-841.2%) | -$82.06 M(-289.0%) |
Sep 2008 | - | $18.06 M(-4.9%) | $43.41 M(+9.9%) |
Jun 2008 | - | $18.99 M(+28.7%) | $39.51 M(+38.3%) |
Mar 2008 | - | $14.75 M(-275.7%) | $28.56 M(+353.2%) |
Dec 2007 | $6.30 M(-78.3%) | -$8.39 M(-159.3%) | $6.30 M(-65.5%) |
Sep 2007 | - | $14.16 M(+76.0%) | $18.25 M(+17.5%) |
Jun 2007 | - | $8.04 M(-207.2%) | $15.52 M(-18.3%) |
Mar 2007 | - | -$7.50 M(-311.5%) | $18.99 M(-34.5%) |
Dec 2006 | $28.98 M(-32.4%) | $3.55 M(-69.0%) | $28.98 M(-19.0%) |
Sep 2006 | - | $11.43 M(-0.7%) | $35.79 M(-8.0%) |
Jun 2006 | - | $11.52 M(+363.6%) | $38.89 M(+0.9%) |
Mar 2006 | - | $2.48 M(-76.0%) | $38.54 M(-10.2%) |
Dec 2005 | $42.89 M(+224.7%) | $10.36 M(-28.8%) | $42.89 M(+10.4%) |
Sep 2005 | - | $14.54 M(+30.2%) | $38.85 M(+29.4%) |
Jun 2005 | - | $11.16 M(+63.2%) | $30.01 M(+33.9%) |
Mar 2005 | - | $6.84 M(+8.3%) | $22.42 M(+69.7%) |
Dec 2004 | $13.21 M(-214.6%) | $6.31 M(+10.8%) | $13.21 M(+291.6%) |
Sep 2004 | - | $5.70 M(+59.6%) | $3.37 M(-182.9%) |
Jun 2004 | - | $3.57 M(-250.5%) | -$4.07 M(-61.1%) |
Mar 2004 | - | -$2.37 M(-32.6%) | -$10.47 M(-9.2%) |
Dec 2003 | -$11.53 M(-36.0%) | -$3.52 M(+102.1%) | -$11.53 M(+3.7%) |
Sep 2003 | - | -$1.74 M(-38.4%) | -$11.12 M(-30.1%) |
Jun 2003 | - | -$2.83 M(-17.6%) | -$15.91 M(+10.0%) |
Mar 2003 | - | -$3.43 M(+10.2%) | -$14.46 M(-19.7%) |
Dec 2002 | -$18.00 M(-61.6%) | -$3.11 M(-52.4%) | -$18.00 M(-26.2%) |
Sep 2002 | - | -$6.54 M(+374.0%) | -$24.40 M(-18.0%) |
Jun 2002 | - | -$1.38 M(-80.2%) | -$29.76 M(-28.0%) |
Mar 2002 | - | -$6.97 M(-26.7%) | -$41.36 M(-10.6%) |
Dec 2001 | -$46.94 M(-42.4%) | -$9.51 M(-20.0%) | -$46.28 M(-31.8%) |
Sep 2001 | - | -$11.90 M(-8.3%) | -$67.83 M(+2.2%) |
Jun 2001 | - | -$12.97 M(+9.1%) | -$66.36 M(-20.9%) |
Mar 2001 | - | -$11.89 M(-61.7%) | -$83.91 M(+3.0%) |
Dec 2000 | -$81.50 M(+130.5%) | -$31.07 M(+198.1%) | -$81.50 M(+36.1%) |
Sep 2000 | - | -$10.42 M(-65.8%) | -$59.89 M(+5.9%) |
Jun 2000 | - | -$30.52 M(+221.6%) | -$56.57 M(+75.4%) |
Mar 2000 | - | -$9.49 M(+0.3%) | -$32.25 M(-8.0%) |
Dec 1999 | -$35.36 M(+165.0%) | -$9.46 M(+33.3%) | -$35.06 M(+37.0%) |
Sep 1999 | - | -$7.10 M(+14.5%) | -$25.60 M(+38.4%) |
Jun 1999 | - | -$6.20 M(-49.6%) | -$18.50 M(+50.4%) |
Mar 1999 | - | -$12.30 M | -$12.30 M |
Dec 1998 | -$13.35 M | - | - |
FAQ
- What is United Therapeutics annual operating income?
- What is the all time high annual operating profit for United Therapeutics?
- What is United Therapeutics annual operating profit year-on-year change?
- What is United Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for United Therapeutics?
- What is United Therapeutics quarterly operating profit year-on-year change?
- What is United Therapeutics TTM operating income?
- What is the all time high TTM operating profit for United Therapeutics?
- What is United Therapeutics TTM operating profit year-on-year change?
What is United Therapeutics annual operating income?
The current annual operating profit of UTHR is $1.18 B
What is the all time high annual operating profit for United Therapeutics?
United Therapeutics all-time high annual operating income is $1.18 B
What is United Therapeutics annual operating profit year-on-year change?
Over the past year, UTHR annual operating income has changed by +$205.20 M (+20.95%)
What is United Therapeutics quarterly operating income?
The current quarterly operating profit of UTHR is $408.20 M
What is the all time high quarterly operating profit for United Therapeutics?
United Therapeutics all-time high quarterly operating income is $408.20 M
What is United Therapeutics quarterly operating profit year-on-year change?
Over the past year, UTHR quarterly operating income has changed by +$81.20 M (+24.83%)
What is United Therapeutics TTM operating income?
The current TTM operating profit of UTHR is $1.34 B
What is the all time high TTM operating profit for United Therapeutics?
United Therapeutics all-time high TTM operating income is $1.34 B
What is United Therapeutics TTM operating profit year-on-year change?
Over the past year, UTHR TTM operating income has changed by +$244.10 M (+22.18%)